Athanasios Tsianakas

2.3k total citations
57 papers, 1.1k citations indexed

About

Athanasios Tsianakas is a scholar working on Dermatology, Immunology and Rheumatology. According to data from OpenAlex, Athanasios Tsianakas has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Dermatology, 20 papers in Immunology and 14 papers in Rheumatology. Recurrent topics in Athanasios Tsianakas's work include Dermatology and Skin Diseases (26 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Athanasios Tsianakas is often cited by papers focused on Dermatology and Skin Diseases (26 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Athanasios Tsianakas collaborates with scholars based in Germany, United States and France. Athanasios Tsianakas's co-authors include Thomas A. Luger, Sonja Ständer, Claudia Zeidler, Jan Ehrchen, Peter H. Hoeger, Cord Sunderkoetter, Georg Varga, Johannes Roth, Klaus Tenbrock and Allen Radin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Athanasios Tsianakas

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Athanasios Tsianakas Germany	20	552	398	252	190	175	57	1.1k
Alessandra Narcisi Italy	19	448 0.8×	459 1.2×	145 0.6×	98 0.5×	137 0.8×	105	886
Vimal H. Prajapati Canada	13	588 1.1×	249 0.6×	179 0.7×	279 1.5×	179 1.0×	87	861
Koremasa Hayama Japan	12	298 0.5×	536 1.3×	439 1.7×	163 0.9×	192 1.1×	47	930
Claudio Bonifati Italy	22	433 0.8×	838 2.1×	346 1.4×	38 0.2×	159 0.9×	53	1.3k
Joseph Wee Singapore	6	424 0.8×	253 0.6×	160 0.6×	203 1.1×	109 0.6×	7	1.5k
E. Castela France	12	438 0.8×	442 1.1×	68 0.3×	80 0.4×	51 0.3×	14	860
Alice B. Gottlieb United States	10	339 0.6×	533 1.3×	84 0.3×	47 0.2×	73 0.4×	19	915
Emanuela Martina Italy	17	285 0.5×	222 0.6×	195 0.8×	48 0.3×	189 1.1×	49	770
Marianne Notter Switzerland	5	732 1.3×	1.3k 3.2×	342 1.4×	39 0.2×	266 1.5×	9	1.6k
Stanley Cheuk Sweden	10	421 0.8×	1.1k 2.9×	95 0.4×	30 0.2×	151 0.9×	13	1.4k

Countries citing papers authored by Athanasios Tsianakas

Since Specialization

Citations

This map shows the geographic impact of Athanasios Tsianakas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Tsianakas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Tsianakas more than expected).

Fields of papers citing papers by Athanasios Tsianakas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Tsianakas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Tsianakas. The network helps show where Athanasios Tsianakas may publish in the future.

Co-authorship network of co-authors of Athanasios Tsianakas

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Tsianakas. A scholar is included among the top collaborators of Athanasios Tsianakas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Tsianakas. Athanasios Tsianakas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeidler, Claudia, et al.. (2024). Acceptability and perceived benefits of validated pruritus assessment instruments in the dermatological office and clinic: The perspectives of patients and physicians. Journal of the European Academy of Dermatology and Venereology. 38(10). 1973–1981. 1 indexed citations

Reich, Kristian, Luca Bianchi, A. Khemis, et al.. (2024). Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA). Dermatology and Therapy. 14(2). 453–468. 3 indexed citations

Magnolo, Nina, Thomas Jaenicke, Athanasios Tsianakas, et al.. (2023). Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 37(S5). 18–26. 11 indexed citations

Sommer, Rachel, et al.. (2023). A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis. Acta Dermato Venereologica. 103. adv3962–adv3962. 11 indexed citations

Bissonnette, Robert, et al.. (2021). A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis. Dermatology and Therapy. 11(6). 2179–2193. 10 indexed citations

Porcu, Pierluigi, Stacie Hudgens, Sarah McCue Horwitz, et al.. (2020). Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(2). 97–105. 20 indexed citations

Tsianakas, Athanasios, Claudia Baumann, Claudia Riepe, et al.. (2018). 399 Blockade of the IL-12/IL-23 pathway with ustekinumab modulates the composition of the microbiome in lesional skin from psoriasis patients. Journal of Investigative Dermatology. 138(5). S68–S68. 1 indexed citations

Werfel, Thomas, Gary Layton, Michael Yeadon, et al.. (2018). Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 143(5). 1830–1837.e4. 98 indexed citations

Krause, Karoline, Athanasios Tsianakas, Nicola Wagner, et al.. (2016). Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study. Journal of Allergy and Clinical Immunology. 139(4). 1311–1320. 71 indexed citations

10.

Ständer, Sonja, Christine Blome, Claudia Zeidler, et al.. (2016). Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus. Acta Dermato Venereologica. 97(2). 230–234. 27 indexed citations

11.

Tsianakas, Athanasios & TA Luger. (2015). The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis. Expert Opinion on Biological Therapy. 15(11). 1657–1660. 13 indexed citations

12.

Ständer, Sonja, Martin Metz, Marcus Maurer, et al.. (2014). Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local Tolerability. Acta Dermato Venereologica. 96(6). 0–0. 7 indexed citations

13.

Thoma-Uszynski, Sybille, Ilka Herrgott, Athanasios Tsianakas, et al.. (2013). Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers. European Journal of Dermatology. 23(2). 218–223. 4 indexed citations

14.

Ehrchen, Jan, Nadine Nippe, Athanasios Tsianakas, et al.. (2012). Glucocorticoid-Stimulated Monocytes (GCsM) Control T Cell-Induced Colitis in Vivo. 1. 25–25. 1 indexed citations

15.

Tsianakas, Athanasios, Georg Varga, Katarzyna Barczyk, et al.. (2011). Induction of an anti-inflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10. Immunobiology. 217(3). 329–335. 30 indexed citations

16.

Tsianakas, Athanasios, Peter Hensen, D. Nashan, et al.. (2011). Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma. Journal of the European Academy of Dermatology and Venereology. 26(1). 71–78. 20 indexed citations

17.

Gutzmer, Ralf, Jürgen C. Becker, Alexander Enk, et al.. (2010). Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 9(3). 195–202. 31 indexed citations

18.

Tsianakas, Athanasios, Meinhard Schiller, Thomas A. Luger, & Cord Sunderkötter. (2009). The option of compassionate use in metastatic melanoma – way out of a therapeutic dilemma?. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 7(8). 671–678. 1 indexed citations

19.

Tsianakas, Athanasios, Jan Ehrchen, Dagmar Presser, et al.. (2009). Scalp necrosis in giant cell arteritis: Case report and review of the relevance of this cutaneous sign of large-vessel vasculitis. Journal of the American Academy of Dermatology. 61(4). 701–706. 39 indexed citations

20.

Tsianakas, Athanasios, et al.. (2007). Werner-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 132(3). 91–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact